ClinicalTrials.Veeva

Menu

Interventional Radiology in Bony Lesions

A

Assiut University

Status

Not yet enrolling

Conditions

Bone Lesion

Treatments

Procedure: radiofrequency ablation
Procedure: angioembolization

Study type

Observational

Funder types

Other

Identifiers

NCT05738941
bone interventional radiology

Details and patient eligibility

About

To explore the capability of the interventional radiology techniques in management of the painful bony lesions .

Full description

Bone tumors may present as incidental findings, with pain or loss of function, or as fractures [1].

Interventional Radiology (IR) has experienced an exponential growth in recent years. Technological advances of the last decades have made it possible to use new treatments on a larger scale, with good results in terms of safety and effectiveness[2] .

Today, IR represents a minimally invasive option of treatment for benign bony lesions (osteoid osteoma [OO], osteoblastoma, periosteal chondroma, etc.) and for palliation of metastases involving bone and soft-tissue sites beyond the liver and lung in an always-increasing number of cases [3][4].

The aim of minimally-invasive ablation treatment is addressing the biological pain due to the stretching and irritation of the periosteum secondary to tumor growth and due to osteoclast-mediated bone resorption with the release of neurostimulating cytokines. The purpose of cementoplasty is to treat the mechanical pain for the instability from pathologic microfractures [5] Radiofrequency ablation (RFA) and cementoplasty are safe, feasible, and promising clinical option for the management of painful bony tumors that are challenging for their morphology and location [6].

Also , there is a broad range of indications for transarterial embolization (TAE) in primary or metastatic bone tumors: to reduce operative haemorrhagic risks, to simplify or allow more definitive surgery, or in the context of pain palliation, fever, bleeding, or hypercalcemic and other rheological factors[1].

Enrollment

50 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Painful primary bone tumors .
  2. Bone secondaries not amenable to radiation therapy .
  3. histopathologically radioresistant bony tumors.
  4. Painful osteoporotic vertebral fractures.

Exclusion criteria

  • 1- Contraindications to contrast media 2- Raised renal chemistry or chronic kidney disease . 3- Pregnant patients . 4- Abnormal coagulation profile . 5- Contraindications to anesthesia .

Trial contacts and locations

0

Loading...

Central trial contact

Momtaz Mohamed, MD; Mostafa Othman, PHD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems